epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Cardiovascular

Subclasses

  • Aldosterone Synthase Inhibitors
  • Alpha Agonists, Cardiovascular
  • Alpha Blockers, Peripheral
  • Angiotensin Receptor Blocker (ARB)/ Thiazide Combos
  • Angiotensin Receptor Blockers (ARBs)
  • Angiotensin-Converting Enzyme (ACE) Inhibitor/ Thiazide Combos
  • Angiotensin-Converting Enzyme (ACE) Inhibitors
  • Antianginals
  • Antiarrhythmics, Intranasal
  • Antiarrhythmics, Oral
  • Antiarrhythmics, Parenteral
  • Anticoagulant Reversal Agents
  • Anticoagulants
  • Antiplatelets, Cardiovascular
  • Beta Blocker/ Thiazide Combos
  • Beta Blockers
  • Calcium Channel Blockers (CCBs), Dihydropyridines
  • Calcium Channel Blockers (CCBs), Non-dihydropyridines
  • Cardiac Amyloidosis
  • Cardiovascular Inflammation
  • CHAPLE Disease
  • Claudication
  • Colloids
  • Diagnostic Agents, Cardiovascular
  • Direct Renin Inhibitors
  • Diuretics, Carbonic Anhydrase Inhibitors
  • Diuretics, Loop
  • Diuretics, Osmotic
  • Diuretics, Potassium-sparing
  • Diuretics, Thiazides
  • Dyslipidemia: Adenosine Triphosphate-Citrate Lyase (ACL) Inhibitors
  • Dyslipidemia: Angiopoietin-Like 3 (ANGPTL3) Inhibitors
  • Dyslipidemia: Apolipoprotein C-III (APOC3) Inhibitors
  • Dyslipidemia: Bile Acid Sequestrants
  • Dyslipidemia: Cholesterol Absorption Inhibitors
  • Dyslipidemia: Fibrates
  • Dyslipidemia: HMG-CoA Reductase Inhibitors (Statins)
  • Dyslipidemia: MTP Inhibitors
  • Dyslipidemia: Niacin
  • Dyslipidemia: Omega-3 Fatty Acids
  • Dyslipidemia: PCSK9 Inhibitors
  • Dyslipidemia: PCSK9 Small Interfering Ribonucleic Acids (siRNAs)
  • Endothelin Receptor Antagonists, Cardiovascular
  • GLP-1 Agonists, Cardiovascular
  • HCN Channel Blockers
  • Hypertrophic Cardiomyopathy: Ablative Agents
  • Hypertrophic Cardiomyopathy: Cardiac Myosin Inhibitors
  • Inotropes/ Pressors
  • Mineralocorticoid (Aldosterone) Receptor Antagonists
  • Mineralocorticoid Receptor Antagonists, Nonsteroidal
  • Mitochondrial Diseases, Cardiovascular
  • Neprilysin Inhibitors
  • Patent Ductus Arteriosus
  • Pulmonary Arterial Hypertension (PAH)
  • Sclerosing Agents, Vascular
  • SGLT1 Inhibitors, Cardiovascular
  • SGLT2 Inhibitors, Cardiovascular
  • soluble Guanylate Cyclase (sGC) Stimulators
  • Thrombolytics, Oligonucleotides
  • Thrombolytics, Recombinant Tissue Plasminogen Activators (rtPA)
  • Tyrosine Hydroxylase Inhibitors
  • Vasodilators/ Nitrates

Diuretics, Loop

Drug Names

Generic Names

bumetanide generic  
Bumex bumetanide  
Demadex torsemide  
Edecrin ethacrynic acid  
Enbumyst bumetanide nasal  
ethacrynic acid generic  
Furoscix furosemide  
furosemide generic  
Lasix furosemide  
Lasix Onyu furosemide  
Soaanz torsemide  
torsemide generic  

close

 

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information